CD8A and COVID-19: Therefore, we first tested the immunogenicity of the YLQ peptide in three COVID-19 recovered individuals by expanding CD8+ T cells against peptide pools, including the YLQ peptide and performed an intracellular cytokine staining assay to determine the immunogenicity.